pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Aug 11·1 min read
save

Abbott partners with Google Health to add AI-driven insights to its Lingo glucose wearable

Aug 11, 2026·read at Fierce Biotech ↗DealPositive

Abbott and Google Health announced a partnership that will combine Abbott's Lingo consumer glucose wearable with Google Health's artificial‑intelligence platform.

The integration will let Lingo users view glucose trends alongside other health and wellness metrics within the Google Health app, creating a single, unified health picture.

Google Health's AI Coach will analyze the combined data to offer personalized recommendations on nutrition, activity, sleep and recovery, helping users understand how daily behaviors affect their well‑being.

Lingo, launched in 2024 as an over‑the‑counter continuous glucose monitor for adults not using insulin, gains AI‑driven insights through this collaboration, marking a first‑of‑its‑kind digital health offering.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Abbott teams with Google Health on AI-powered health insights app”

read at Fierce Biotech ↗
425 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
insulin2Type 2 Diabetes
topics
Endocrinology & Metabolism5Type 2 Diabetes3Medical Device Company2HematologyOphthalmology

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • 4d agoNovo’s plan to hit $23B in revenue by 2035 leaves investors wantingBioSpace
  • Sep 9Caspian launches with $50M, Lilly support to advance disease-modifying diabetes betBioSpace
  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT
  • Jul 23Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 dataBioSpace